KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $13.5 million.

  • Jazz Pharmaceuticals' Other Working Capital Changes fell 6047.3% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.5 million, marking a year-over-year decrease of 10967.85%. This contributed to the annual value of -$14.5 million for FY2024, which is 11151.62% down from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Other Working Capital Changes is $13.5 million, which was down 6047.3% from $28.1 million recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Other Working Capital Changes registered a high of $88.9 million during Q4 2023, and its lowest value of -$54.9 million during Q1 2024.
  • Its 5-year average for Other Working Capital Changes is $8.7 million, with a median of $13.4 million in 2021.
  • Per our database at Business Quant, Jazz Pharmaceuticals' Other Working Capital Changes plummeted by 58533.72% in 2022 and then soared by 1178604.65% in 2023.
  • Jazz Pharmaceuticals' Other Working Capital Changes (Quarter) stood at $48.6 million in 2021, then tumbled by 124.67% to -$12.0 million in 2022, then surged by 841.24% to $88.9 million in 2023, then crashed by 115.56% to -$13.8 million in 2024, then soared by 197.69% to $13.5 million in 2025.
  • Its last three reported values are $13.5 million in Q3 2025, $28.1 million for Q2 2025, and -$36.3 million during Q1 2025.